Search

Search Constraints

You searched for: Author/Creator Jessen, Kasper

Search Results

2. Cortical structures and their clinical correlates in antipsychotic-naïve schizophrenia patients before and after 6 weeks of dopamine D2/3 receptor antagonist treatment. Issue 5 (8th May 2018)

3. Danish General Practitioners' Use of Prostate-Specific Antigen in Opportunistic Screening for Prostate Cancer: A Survey Comprising 174 GPs. (19th November 2013)

4. Differential effects of age at illness onset on verbal memory functions in antipsychotic-naïve schizophrenia patients aged 12–43 years. Issue 9 (11th July 2021)

5. F16. GLUTAMATE AND GABA LEVELS IN ANTIPSYCHOTIC-NAïVE SCHIZOPHRENIA PATIENTS ARE ASSOCIATED WITH TREATMENT OUTCOME AFTER 1.5 AND 6 MONTHS. (1st April 2018)

6. F176. CLINICAL CORRELATES OF CORTICAL STRUCTURE IN ANTIPSYCHOTIC-NAïVE SCHIZOPHRENIA PATIENTS BEFORE AND AFTER SIX-WEEK TREATMENT WITH A DOPAMINE D2/3 RECEPTOR ANTAGONIST. (1st April 2018)

7. M143. REGIONAL CEREBRAL BLOOD FLOW IN INITIALLY ANTIPSYCHOTIC-NAïVE PATIENTS WITH SCHIZOPHRENIA OR PSYCHOSIS: EFFECTS OF PARTIAL D2 RECEPTOR AGONISM AND ASSOCIATION WITH SYMPTOM IMPROVEMENT. (18th May 2020)

8. O6.3. ASSOCIATIONS BETWEEN COGNITIVE FUNCTION AND CORTICAL LEVELS OF GLUTAMATE AND GABA IN ANTIPSYCHOTIC-NAïVE PATIENTS WITH SCHIZOPHRENIA OR PSYCHOSIS. (18th May 2020)

9. O7.4. ASSOCIATIONS BETWEEN DOPAMINE SYNTHESIS CAPACITY, GLUTAMATE AND GABA LEVELS IN ANTIPSYCHOTIC-NAïVE PATIENTS WITH FIRST EPISODE PSYCHOSIS. (9th April 2019)

10. O8.1. ASSOCIATIONS BETWEEN REWARD ALTERATIONS AND THALAMIC GLUTAMATE LEVELS IN ANTIPSYCHOTIC-NAïVE FIRST-EPISODE PATIENTS WITH PSYCHOSES. (9th April 2019)